Pocapavir

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePocapavir
Drug Alias NamePocapavirum泊卡帕韦Sch-48973V-073
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCapsid protein inhibitors
TargetsCapsid protein
Therapy Area/IndicationsPoliomyelitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVirodefenseMerck Sharp & Dohme Corp
Active IndicationsN/A
Inactive IndicationsPoliomyelitis

Other Information

ATC CodeN/A
Related LinksN/A